Ho-Sup Lee

14PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical virologyMolecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 03, 2026
Prospective, multicentre phase II study to evaluate the clinical benefit of reduced-dose lenalidomide and dexamethasone based on frailty stratification in elderly, unfit patients with newly diagnosed multiple myeloma.

|Nov 28, 2025
A multicentre prospective phase II study of rituximab combined with bortezomib, lenalidomide and dexamethasone, followed by lenalidomide maintenance (R-VRD) in patients with Waldenström's macroglobulinaemia (KMM1803).

Sung-Hoon Jung, Dajung Kim, Je-Jung Lee

|Apr 28, 2025
A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI-eIF2α-ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies.

Min-Jung Kim, Jinsook Kwak, Hyung Seok Kim

|Mar 11, 2025
Comprehensive clinico-genetic analysis reveals prognostic factors of blastic plasmacytoid dendritic cell neoplasm.

Ji Hyun Lee, Sung-Yong Oh, Taek Gyu Lee

|Sep 23, 2022
Chronic Hepatitis B Viral Activity Enough to Take Antiviral Drug Could Predict the Survival Rate in Malignant Lymphoma.

Kwang-Il Seo, Jae-Cheol Jo, Da-Jung Kim

|Sep 22, 2022
Optimal timing of treatment at relapse after autologous stem cell transplantation in patients with multiple myeloma: a study of the Korean Multiple Myeloma Working Party (KMM-1909).

Sung-Hoon Jung, Chang-Ki Min, Jae Hoon Lee

Pageof 3

Frequent Collaborators

3 joint publications

Jee-Yeong Jeong

2 joint publications

Sung-Soo Yoon

2 joint publications

Jae-Cheol Jo

2 joint publications

Da-Jung Kim